加载中
Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development. Its pipeline includes GV104, a buccal film technology designed to address respiratory and/or nervous system depression in military personnel and chemical incident responders, which has already finished its Phase 1 trial. Another significant project is GV023, an oral version of infliximab, engineered to resolve the key inconvenience of the standard intravenous treatment by eliminating the need for recurring infusions. Established in 2017, Canton Strategic Holdings Inc. is headquartered in Red Bank, New Jersey.
前收盘价
US$2.11
US$0.00 · 0.00%
盘后
US$2.11
US$0.00 · 0.00%
10月12日 16:01 ET
盘中时间采用ET。市场数据可能有所延迟。
Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development. Its pipeline includes GV104, a buccal film technology designed to address respiratory and/or nervous system depression in military personnel and chemical incident responders, which has already finished its Phase 1 trial. Another significant project is GV023, an oral version of infliximab, engineered to resolve the key inconvenience of the standard intravenous treatment by eliminating the need for recurring infusions. Established in 2017, Canton Strategic Holdings Inc. is headquartered in Red Bank, New Jersey.
日内区间
当前US$2.11
52周区间
当前US$2.11
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 研究与开发 | 307.4万 USD | 639.21万 USD | 355.96万 USD | 227.84万 USD | 184.28万 USD |
| 销售、一般及管理费用 | 1703.21万 USD | 604.17万 USD | 589.56万 USD | 460.35万 USD | 136.52万 USD |
| 营业费用 | 2010.61万 USD | 1243.38万 USD | 945.52万 USD | 688.19万 USD | 320.8万 USD |
| 利息收入 | 4.14万 USD | 24.99万 USD | 15.26万 USD | — | — |
| 利息支出 | 2.83万 USD | 1.37万 USD | 1.65万 USD | 159.12万 USD | 83.13万 USD |
| 折旧和摊销 | 2201.04万 USD | — | 945.52万 USD | 156.9万 USD | — |
| 营业利润 | −2010.61万 USD | −1243.38万 USD | −945.52万 USD | −688.19万 USD | −320.8万 USD |
| 净利润 | −3591.63万 USD | −1219.76万 USD | −931.91万 USD | −847.32万 USD | −220.66万 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2024年5月28日 | 1:15 | — | — |
股票拆分 | 2023年11月21日 | 1:25 | — | — |
已生效 2024年5月28日
1:15
已生效 2023年11月21日
1:25
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI499.03万0.00%2.3万亿 USD0.03%US$381.58-0.09%
iShares Russell 2000 ETFIWM320.7万0.00%787.4亿 USD0.19%US$277.88-0.38%
Vanguard Extended Market ETFVXF181.87万0.00%954亿 USD0.05%US$233.46-0.66%
ARK Blockchain & Fintech Innovation ETFARKF88.48万0.10%7.01亿 USD0.75%US$47.51-0.17%
Vanguard Russell 2000 ETFVTWO57.77万0.00%180亿 USD0.06%US$112.27-0.35%
iShares Micro-Cap ETFIWC43.37万0.03%13.17亿 USD0.60%US$181.76-0.68%
Onchain Economy ETFNODE29.6万0.44%6792.81万 USD0.67%US$37.07-0.79%
Vanguard Russell 2000 Value ETFVTWV9.37万0.01%14亿 USD0.06%US$186.07+0.14%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFARK Blockchain & Fintech Innovation ETFARKFVanguard Russell 2000 ETFVTWOiShares Micro-Cap ETFIWCOnchain Economy ETFNODEVanguard Russell 2000 Value ETFVTWVAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
